Impaired subendocardial perfusion in patients with metabolic syndrome

1. Fantin, F, Di Francesco, V, Rossi, A, et al. Abdominal obesity and subclinical vascular damage in the elderly. J Hypertens 2010; 28: 333–339.
Google Scholar | Crossref | Medline | ISI2. Yue, M, Liu, H, He, M, et al. Gender-specific association of metabolic syndrome and its components with arterial stiffness in the general Chinese population. PLoS One 2017; 12: 1–15.
Google Scholar | Crossref3. Lopes-Vicente, WRP, Rodrigues, S, Cepeda, FX, et al. Arterial stiffness and its association with clustering of metabolic syndrome risk factors. Diabetol Metab Syndr 2017; 9: 1–8.
Google Scholar | Crossref | Medline4. Topouchian, J, Labat, C, Gautier, S, et al. Effects of metabolic syndrome on arterial function in different age groups: the advanced approach to arterial stiffness study. J Hypertens 2018; 36: 824–833.
Google Scholar | Crossref | Medline5. Vlachopoulos, C, Xaplanteris, P, Aboyans, V, et al. The role of vascular biomarkers for primary and secondary prevention. a position paper from the European society of cardiology working group on peripheral circulation. endorsed by the association for research into arterial structure and physiology (ARTERY). Atherosclerosis 2015; 241: 507–532.
Google Scholar | Crossref | Medline | ISI6. Ekart, R, Bevc, S, Hojs, N, et al. Albuminuria is associated with subendocardial viability ratio in chronic kidney disease patients. Kid Blood Press Res 2015; 40: 565–574.
Google Scholar | Crossref | Medline7. Buckberg, GD, Fixler, DE, Archie, JP, et al. Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res 1972; 30: 67–81.
Google Scholar | Crossref | Medline | ISI8. Sarnoff, SJ, Braunwald, E, Welch, GH, et al. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. Am J Physiol 1958; 192: 148–156.
Google Scholar | Crossref | Medline | ISI9. Salvi, P, Revera, M, Faini, A, et al. Changes in subendocardial viability ratio with acute high-altitude exposure and protective role of acetazolamide. Hypertension 2013; 61: 793–799.
Google Scholar | Crossref | Medline10. Tsiachris, D, Tsioufis, C, Syrseloudis, D, et al. Subendocardial viability ratio as an index of impaired coronary flow reserve in hypertensives without significant coronary artery stenoses. J Hum Hypertens 2012; 26: 64–70.
Google Scholar | Crossref | Medline11. Scandale, G, Dimitrov, G, Recchia, M, et al. Arterial stiffness and subendocardial viability ratio in patients with peripheral arterial disease. J Clin Hypertens 2018; 20: 478–484.
Google Scholar | Crossref12. Mosimann, K, Jacomella, V, Thalhammer, C, et al. Severity of peripheral arterial disease is associated with aortic pressure augmentation and subendocardial viability ratio. J Clin Hypertens 2012; 14: 855–860.
Google Scholar | Crossref13. Brazier, J, Cooper, N, Buckberg, G. The adequacy of subendocardial oxygen delivery: the interaction of determinants of flow, arterial oxygen content and myocardial oxygen need. Circulation 1974; 49: 968–977.
Google Scholar | Crossref | Medline | ISI14. Borkon, AM, Jones, M, Bell, JH, et al. Regional myocardial blood flow in left ventricular hypertrophy. An experimental investigation in Newfoundland dogs with congenital subaortic stenosis. J Thorac Cardiovasc Surg 1982; 84: 876–885.
Google Scholar | Crossref | Medline15. Buckberg, G, Eber, L, Herman, M, et al. Ischemia in aortic stenosis: Hemodynamic prediction. Am J Cardiol 1975; 35: 778–784.
Google Scholar | Crossref | Medline16. Müller, C, Goliasch, G, Schachinger, S, et al. Transcatheter aortic valve replacement (TAVR) leads to an increase in the subendocardial viability ratio assessed by pulse wave analysis. PLoS One 2018; 13: 1–11.
Google Scholar | Crossref17. Ekart, R, Bevc, S, Hojs, N, et al. Relationship between subendocardial viability ratio and hemoglobin in patients with chronic kidney disease. Clin Nephrol 2017; 88: 22–26.
Google Scholar | Crossref | Medline18. Ekart, R, Bevc, S, Hojs, N, et al. Derived subendocardial viability ratio and cardiovascular events in patients with chronic kidney disease. Cardio Renal Med 2019; 9: 41–50.
Google Scholar | Crossref | Medline19. Saito, M, Kasuya, A. Relationship between the subendocardial viability ratio and risk factors for ischemic heart disease. Sangyo Eiseigaku Zasshi 2003; 45: 114–119.
Google Scholar | Crossref | Medline20. Di Pino, A, Alagona, C, Piro, S, et al. Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. Atherosclerosis 2012; 223: 458–462.
Google Scholar | Crossref | Medline21. Radhakrishnan, J, Swaminathan, N, Pereira, NM, et al. Acute changes in arterial stiffness following exercise in people with metabolic syndrome. Diabetes Metab Syndr Clin Res Rev 2017; 11: 237–243.
Google Scholar | Crossref | Medline22. O’Rourke, M . Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension 1990; 15(4): 339–347.
Google Scholar | Crossref | Medline23. Benetos, A, Safar, M, Rudnichi, A, et al. Pulse pressure: A predictor of long-term cardiovascular mortality in a french male population. Hypertension 1997; 30: 1410–1415.
Google Scholar | Crossref | Medline | ISI24. Franklin, SS, Khan, SA, Wong, ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The framingham heart study. Circulation 1999; 100: 354–360.
Google Scholar | Crossref | Medline | ISI25. Salvi, P, Lio, G, Labat, C, et al. Validation of a new non-invasive portable tonometer for determining arterial pressure wave and pulse wave velocity: The pulse pen device. J Hypertens 2004; 22: 2285–2293.
Google Scholar | Crossref | Medline | ISI26. Pichler, G, Martinez, F, Vicente, A, et al. Pulse pressure amplification and its determinants. Blood Press 2016; 25: 21–27.
Google Scholar | Crossref | Medline27. Salvi, P . Pulse Waves: How Vascular Hemodynamics Affects Blood Pressure, 2012. Epub ahead of print 2012. DOI: 10.1007/978-88-470-2439-7_1.
Google Scholar | Crossref28. Hoffman, JIE, Buckberg, GD. The myocardial supply: Demand ratio-a critical review. Am J Cardiol 1978; 41: 327–332.
Google Scholar | Crossref | Medline29. Barnard, RJ, MacAlpin, R, Kattus, AA, et al. Ischemic response to sudden strenuous exercise in healthy men. Circulation 1973; 48: 936–942.
Google Scholar | Crossref | Medline30. Griggs, DM, Chen, CC. Coronary hemodynamics and regional myocardial metabolism in experimental aortic insufficiency. J Clin Invest 1974; 53: 1599–1606.
Google Scholar | Crossref | Medline31. Expert Panel on Detection and Treatment of High Blood Cholesterol in Adults . Executive summary of the third report of the national cholesterol (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Assoc 2001; 285: 2486–2487.
Google Scholar | Crossref32. Grundy, SM, Cleeman, JI, Daniels, SR, et al. Diagnosis and management of the metabolic syndrome. Circulation 2005; 112: 2735–2752.
Google Scholar | Crossref | Medline | ISI33. Friedewald, WT, Levy, RI, Fredrickson, DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
Google Scholar | Crossref | Medline | ISI34. Anyfanti, P, Gkaliagkousi, E, Triantafyllou, A, et al. Noninvasive assessment of myocardial perfusion in different blood pressure phenotypes and its association with arterial stiffness indices. Am J Hypertens 2019; 32: 557–563.
Google Scholar | Crossref | Medline35. Brooks, B, Molyneaux, L, Yue, DK. Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care 1999; 22: 1722–1727.
Google Scholar | Crossref | Medline | ISI36. Jia, G, Hill, MA, Sowers, JR. Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity. Circ Res 2018; 122: 624–638.
Google Scholar | Crossref | Medline37. Fantin, F, Disegna, E, Manzato, G, et al. Adipokines and arterial stiffness in the elderly. Vasc Heal Risk Manag 2020; 16: 535–543.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif